Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2018 Mar 29;13(3):e0194087.
doi: 10.1371/journal.pone.0194087. eCollection 2018.

Community-based MDR-TB care project improves treatment initiation in patients diagnosed with MDR-TB in Myanmar

Affiliations

Community-based MDR-TB care project improves treatment initiation in patients diagnosed with MDR-TB in Myanmar

Pyae Phyo Wai et al. PLoS One. .

Abstract

Background: The Union in collaboration with national TB programme (NTP) started the community-based MDR-TB care (CBMDR-TBC) project in 33 townships of upper Myanmar to improve treatment initiation and treatment adherence. Patients with MDR-TB diagnosed/registered under NTP received support through the project staff, in addition to the routine domiciliary care provided by NTP staff. Each township had a project nurse exclusively for MDR-TB and 30 USD per month (max. for 4 months) were provided to the patient as a pre-treatment support.

Objectives: To assess whether CBMDR-TBC project's support improved treatment initiation.

Methods: In this cohort study (involving record review) of all diagnosed MDR-TB between January 2015 and June 2016 in project townships, CBMDR-TBC status was categorized as "receiving support" if date of project initiation in patient's township was before the date of diagnosis and "not receiving support", if otherwise. Cox proportional hazards regression (censored on 31 Dec 2016) was done to identify predictors of treatment initiation.

Results: Of 456 patients, 57% initiated treatment: 64% and 56% among patients "receiving support (n = 208)" and "not receiving support (n = 228)" respectively (CBMDR-TBC status was not known in 20 (4%) patients due to missing diagnosis dates). Among those initiated on treatment (n = 261), median (IQR) time to initiate treatment was 38 (20, 76) days: 31 (18, 50) among patients "receiving support" and 50 (26,101) among patients "not receiving support". After adjusting other potential confounders (age, sex, region, HIV, past history of TB treatment), patients "receiving support" had 80% higher chance of initiating treatment [aHR (0.95 CI): 1.8 (1.3, 2.3)] when compared to patients "not receiving support". In addition, age 15-54 years, previous history of TB and being HIV negative were independent predictors of treatment initiation.

Conclusion: Receiving support under CBMDR-TBC project improved treatment initiation: it not only improved the proportion initiated but also reduced time to treatment initiation. We also recommend improved tracking of all diagnosed patients as early as possible.

PubMed Disclaimer

Conflict of interest statement

Competing Interests: The authors have declared that no competing interests exist.

Figures

Fig 1
Fig 1. Map of Myanmar showing 33 CBMDR-TBC project supported townships across four states/regions of upper Myanmar, 2015–16.
*CBMDR-TBC project–community-based multi-drug resistant tuberculosis care project.
Fig 2
Fig 2. Flow chart showing treatment initiation cascade stratified by CBMDR-TBC status among diagnosed MDR-TB patients in 33 CBMDR-TBC project supported townships of upper Myanmar, January 2015-June 2016.
*MDR-TB: Multi drug resistant tuberculosis. aPatient considered receiving support if date of project initiation in patient’s township was before the date of MDR-TB diagnosis, date of MDR-TB diagnosis is missing for 20 patients and therefore could not be classified. bwhether patients were under CBMDR-TBC project or not cannot be ascertained as date of diagnosis was missing. cfollow-up period from diagnosis ranged from 6 months to 2 years.
Fig 3
Fig 3. Time to treatment initiation among patients diagnosed with MDR-TB (overall and stratified by CBMDR-TBC status) between January 2015 and June 2016 in 33 CBMDR-TBC project supported townships in upper Myanmar.
*MDR-TB-Multidrug resistance tuberculosis, CBMDR-TBC- Community based multidrug resistance tuberculosis care project.

Similar articles

Cited by

References

    1. World Health Organization (WHO). Global Tuberculosis Report 2016. Geneva, Switzerland; 2016. doi:ISBN 978 92 4 156539 4
    1. Hossain ST, Isaakidis P, Sagili KD, Islam S, Islam MA, Shewade HD, et al. The Multi-Drug Resistant Tuberculosis Diagnosis and Treatment Cascade in Bangladesh. PLoS One. 2015;10: e0129155 doi: 10.1371/journal.pone.0129155 - DOI - PMC - PubMed
    1. Singla N, Satyanarayana S, Sachdeva KS, Van den Bergh R, Reid T, Tayler-Smith K, et al. Impact of Introducing the Line Probe Assay on Time to Treatment Initiation of MDR-TB in Delhi, India. Sola C, editor. PLoS One. 2014;9: 5 doi: 10.1371/journal.pone.0102989 - DOI - PMC - PubMed
    1. Cox H, Dickson-Hall L, Ndjeka N, van’t Hoog A, Grant A, Cobelens F, et al. Delays and loss to follow-up before treatment of drug-resistant tuberculosis following implementation of Xpert MTB/RIF in South Africa: A retrospective cohort study. Suthar AB, editor. PLOS Med. South African National Department of Health; 2017;14: 19 doi: 10.1371/journal.pmed.1002238 - DOI - PMC - PubMed
    1. Harris RC, Grandjean L, Martin LJ, Miller AJP, Nkang J-EN, Allen V, et al. The effect of early versus late treatment initiation after diagnosis on the outcomes of patients treated for multidrug-resistant tuberculosis: a systematic review. BMC Infect Dis. 2016;16: 193 doi: 10.1186/s12879-016-1524-0 - DOI - PMC - PubMed

Publication types

Substances